News As Brexit trigger nears, UK pharma prepares for different sc... AstraZeneca chief considers two possible scenarios for post-Brexit regulation
News Prime minister accused of being "in denial" about NHS crisis PM under fire over A&E waiting times.
Views & Analysis ‘Quickie divorce’ Brexit not an option for medicines, says U... The UK government wants a 'bespoke' deal for pharma - but the EU has other ideas.
News UK could seek ‘transitional deal’ to cushion Brexit PM also promises corporation tax cuts and innovation investment
Views & Analysis What doctors say about Theresa May’s reappointment of Jeremy... Reactions of healthcare professionals to Jeremy Hunt staying as Health Secretary.
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
